Cerebrospinal fluid creatine phosphokinase in the normal dog

Area of Science:

• Veterinary Neurology
• Biochemistry
• Canine Medicine

Background:

• Creatine phosphokinase (CPK) is an enzyme crucial for cellular energy metabolism.
• Elevated CPK levels in cerebrospinal fluid (CSF) can indicate neurological damage.
• Establishing baseline CPK levels in healthy dogs is essential for diagnostic accuracy.

Purpose of the Study:

• To determine the normal range of creatine phosphokinase enzyme activity in canine cerebrospinal fluid.
• To assess the temporal variability of CPK levels in healthy dogs.
• To explore the potential utility of CSF CPK as a biomarker in canine neurologic disorders.

Main Methods:

• Analysis of 67 cerebrospinal fluid samples from 44 healthy dogs.
• Assay of creatine phosphokinase enzyme activity using standardized laboratory methods.
• Evaluation of intra-individual variations in CPK levels over time.

Main Results:

• All analyzed cerebrospinal fluid samples exhibited creatine phosphokinase activity of 1 Sigma unit or less.
• Minimal temporal variability in creatine phosphokinase levels was observed within individual dogs.
• A consistent and low baseline level of CPK was established for healthy canine CSF.

Conclusions:

• The established low baseline of creatine phosphokinase in healthy canine cerebrospinal fluid provides a critical reference point.
• Understanding normal CPK levels is vital for the accurate diagnosis of neurologic conditions in dogs.
• Further research into the biological characteristics and diagnostic application of CSF CPK in canine neurologic disease is warranted.